Detrusitol Retard Hart forðahylki 2 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

detrusitol retard hart forðahylki 2 mg

upjohn eesv - tolterodinum l-tartrat - hart forðahylki - 2 mg

Detrusitol Retard Hart forðahylki 4 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

detrusitol retard hart forðahylki 4 mg

upjohn eesv - tolterodinum l-tartrat - hart forðahylki - 4 mg

Dostinex Tafla 0,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

dostinex tafla 0,5 mg

pfizer aps - cabergolinum inn - tafla - 0,5 mg

Relpax Filmuhúðuð tafla 40 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

relpax filmuhúðuð tafla 40 mg

upjohn eesv - eletriptanum brómíð - filmuhúðuð tafla - 40 mg

Tafil Tafla 0,25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

tafil tafla 0,25 mg

upjohn eesv - alprazolamum inn - tafla - 0,25 mg

Tafil Tafla 0,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

tafil tafla 0,5 mg

upjohn eesv - alprazolamum inn - tafla - 0,5 mg

Tafil Retard Forðatafla 0,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

tafil retard forðatafla 0,5 mg

upjohn eesv - alprazolamum inn - forðatafla - 0,5 mg

Tafil Retard Forðatafla 1 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

tafil retard forðatafla 1 mg

upjohn eesv - alprazolamum inn - forðatafla - 1 mg

Pylclari Evrópusambandið - íslenska - EMA (European Medicines Agency)

pylclari

curium pet france - piflufolastat (18f) - blöðruhálskirtli - greining geislavirkja - Þetta lyf er eingöngu ætlað til greiningar. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).